@article{LiDengXieetal.2018,
  author    = {Li, Cong and Deng, Xiaobing and Xie, Xiaowen and Liu, Ying and Friedmann Angeli, Jos{\´e} Pedro and Lai, Luhua},
  title     = {Activation of Glutathione Peroxidase 4 as a Novel Anti-inflammatory Strategy},
  series = {Frontiers in Pharmacology},
  volume    = {9},
  journal   = {Frontiers in Pharmacology},
  number    = {1120},
  issn      = {1663-9812},
  doi       = {10.3389/fphar.2018.01120},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-195985},
  year      = {2018},
  abstract  = {The anti-oxidative enzyme, glutathione peroxidase 4 (GPX4), helps to promote inflammation resolution by eliminating oxidative species produced by the arachidonic acid (AA) metabolic network. Up-regulating its activity has been proposed as a promising strategy for inflammation intervention. In the present study, we aimed to study the effect of GPX4 activator on the AA metabolic network and inflammation related pathways. Using combined computational and experimental screen, we identified a novel compound that can activate the enzyme activity of GPX4 by more than two folds. We further assessed its potential in a series of cellular assays where GPX4 was demonstrated to play a regulatory role. We are able to show that GPX4 activation suppressed inflammatory conditions such as oxidation of AA and NF-κB pathway activation. We further demonstrated that this GPX4 activator can decrease the intracellular ROS level and suppress ferroptosis. Our study suggests that GPX4 activators can be developed as anti-inflammatory or cyto-protective agent in lipid-peroxidation-mediated diseases.},
  language  = {en}
}